Integration of mechanism-based in vitro methods and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for prediction of nephrotoxicity

被引:0
|
作者
Mally, A. [1 ]
Birk, B. [2 ]
DiFiore, S. [3 ]
Ellinger, B. [4 ]
Jarzina, S. [1 ]
Taverne, F. [5 ]
Kramer, N. [5 ]
机构
[1] Univ Wurzburg, Dept Toxicol, Wurzburg, Germany
[2] BASF, Expt Toxicol & Ecol, Ludwigshafen, Germany
[3] Fraunhofer Inst Mol Biol & Appl Ecol, Div Mol Biotechnol, Aachen, Germany
[4] Fraunhofer Inst Mol Biol & Appl Ecol, Div Translat Med, Hamburg, Germany
[5] Univ Utrecht, Inst Risk Assessment Sci, Toxicol Div, Utrecht, Netherlands
关键词
D O I
10.1016/j.toxlet.2018.06.1123
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
S08-02
引用
收藏
页码:S27 / S27
页数:1
相关论文
共 50 条
  • [21] Cellular Metabolism in High-Throughput In Vitro Reporter Gene Assays and Implications for the Quantitative In Vitro-In Vivo Extrapolation
    Fischer, Fabian C.
    Abele, Cedric
    Henneberger, Luise
    Kluver, Nils
    Konig, Maria
    Muhlenbrink, Marie
    Schlichting, Rita
    Escher, Beate, I
    CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (07) : 1770 - 1779
  • [22] Quantitative in vitro-to-in vivo extrapolation (QIVIVE) of estrogenic and anti-androgenic potencies of BPA and BADGE analogues
    Punt, Ans
    Aartse, Aafke
    Bovee, Toine F. H.
    Gerssen, Arjen
    van Leeuwen, Stefan P. J.
    Hoogenboom, Ron L. A. P.
    Peijnenburg, Ad A. C. M.
    ARCHIVES OF TOXICOLOGY, 2019, 93 (07) : 1941 - 1953
  • [23] A critical evaluation of the experimental design of studies of mechanism based enzyme inhibition, with implications for in vitro-in vivo extrapolation
    Ghanbari, F
    Rowland-Yeo, K
    Bloomer, JC
    Clarke, SE
    Lennard, MS
    Tucker, GT
    Rostami-Hodjegan, A
    CURRENT DRUG METABOLISM, 2006, 7 (03) : 315 - 334
  • [24] Prediction of metabolic drug clearance in humans:: In vitro-in vivo extrapolation vs allometric scaling
    Shiran, M. R.
    Proctor, N. J.
    Howgate, E. M.
    Rowland-Yeo, K.
    Tucker, G. T.
    Rostami-Hodjegan, A.
    XENOBIOTICA, 2006, 36 (07) : 567 - 580
  • [25] Quantitative in vitro-to-in vivo extrapolation (QIVIVE) of estrogenic and anti-androgenic potencies of BPA and BADGE analogues
    Ans Punt
    Aafke Aartse
    Toine F. H. Bovee
    Arjen Gerssen
    Stefan P. J. van Leeuwen
    Ron L. A. P. Hoogenboom
    Ad A. C. M. Peijnenburg
    Archives of Toxicology, 2019, 93 : 1941 - 1953
  • [26] The unbound fraction of amiodarone is an important parameter for modelling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE)
    Algharably, E.
    Kreutz, R.
    Gundert-Remy, U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S75 - S75
  • [27] Prediction of in vivo nephrotoxicity using an in vitro-in silico approach: The case of aristolochic acid I
    Abdullah, R.
    Alhusainy, W.
    Rietjens, I. M. C.
    Punt, A.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S94 - S94
  • [28] Mechanism-based pharmacokinetic/pharmacodynamic Modeling of the electroencephalogram effects of GABAA receptor modulators:: In vitro-in vivo correlations
    Visser, SAG
    Wolters, FLC
    Gubbens-Stibbe, JM
    Tukker, E
    Van der Graaf, PH
    Peletier, LA
    Danhof, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (01): : 88 - 101
  • [29] Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolation
    Algharably, Engi Abd el-Hady
    Di Consiglio, Emma
    Testai, Emanuela
    Kreutz, Reinhold
    Gundert-Remy, Ursula
    ARCHIVES OF TOXICOLOGY, 2021, 95 (04) : 1433 - 1442
  • [30] Use of quantitative in vitro to in vivo extrapolation (QIVIVE) for the assessment of non-combustible next-generation product aerosols
    Moreau, Marjory
    Simms, Liam
    Andersen, Melvin E.
    Sticken, Edgar Trelles
    Wieczorek, Roman
    Pour, Sarah Jean
    Chapman, Fiona
    Roewer, Karin
    Otte, Sandra
    Fisher, Jeffrey
    Stevenson, Matthew
    FRONTIERS IN TOXICOLOGY, 2024, 6